Caplight Directory>Companies>Fecundis-preview>Fecundis


Fecundis

Fecundis

Private
Buenos AiresHealthcare & Life Scienceshttps://fecundis.com

Last Round

Seed

Oct 8, 2024

Est. Valuation

$6.72M

Total Funding Raised

$3.18M

Company Overview

Fecundis is a biotechnology company that develops sperm-enhancing technologies to increase the success of infertility treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

male infertilitysperm enhancementassisted reproductive technologyARTin vitro fertilizationIVFfertility techcell therapymale factor infertilityfertility treatmentreproductive medicineandrologysemen processing kitex-vivo treatmentbiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fecundis Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Fecundis Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedOct 8, 2024
CrowdfundingJan 10, 2024
View all Funding Rounds

Key People

Founding team and executive leadership

Arina Rogozina

CEO, Chief Executive Officer

Executive Team

Rita Vassena

Chief Executive Officer

Executive Team

Matías Gómez Elías

Chief Operating Officer, R&D Manager

Executive Team

Fecundis Investors

Notable investors and investment history

InvestorRounds
Zentynel Frontier InvestmentsSeed
DuneGlass CapitalSeed
GRIDXSeed
View all Investors

Fecundis Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fecundis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fecundis's valuation, stock price, and market status.

Firmographic Details

HeadquartersBuenos Aires
Employee Range11
Year Founded2020
Last FundingOct 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.